Skip to content

Intracorporeal side-to-side anastomosis in laparoscopic left hemicolectomy (overlap method)

Intracorporeal side-to-side anastomosis in laparoscopic left hemicolectomy (overlap method)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096026
Enrollment
Unknown
Registered
2025-01-16
Start date
2025-01-17
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer

Interventions

Intracorporeal side-to-side anastomosis (overlap method):Laparoscopic left hemicolectomy with intraluminal overlap side-to-side anastomosis.
Traditional intraperitoneal anastomosis group in the past:NA

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosis of left-sided colon cancer (from the left third of the transverse colon to the proximal third of the sigmoid colon) confirmed by colonoscopy and pathology. 2.Planned laparoscopic left hemicolectomy for left-sided colon cancer. 3.Age between 20 and 80 years. 4.No history of previous abdominal surgery that would severely affect the performance of colonic surgery. 5.The patient and their family are willing to participate in this clinical trial. control group 1. Postoperative pathological diagnosis of left colon cancer (from the left one-third of the transverse colon to the proximal one-third of the sigmoid colon); 2. Perform laparoscopic resection of left colon cancer; 3. Age range of 20-80 years old; 4. There is no history of abdominal surgery that significantly affects colon surgery in the past; 5. No invasion or metastasis of other organs, no merger of other tumors; 6. Not combined with intestinal obstruction or incomplete intestinal obstruction.

Exclusion criteria

Exclusion criteria: 1. Presence of other malignancies. 2. Patients with multiple primary cancers. 3. Tumor local invasion requiring combined organ resection. 4. Recurrent tumors. 5. Undergoing open surgery. 6. Patients with bowel obstruction or incomplete bowel obstruction. 7. Patients who refuse to continue participating in the study.

Design outcomes

Primary

MeasureTime frame
quality of life;Total duration of surgery;Pain Assessment Scale Pain Rating Scale;

Secondary

MeasureTime frame
Intraoperative Complications;Pathological Information;Match duration;blood loss;Anal exhaust time;

Countries

China

Contacts

Public ContactMeng Wenjian

Colorectal Cancer Center, Department of General Surgery, West China Hospital

mengwenjian@126.com+86 189 8060 6727

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026